ZELBORAF - 50242-090-01 - (Vemurafenib)

Alphabetical Index


Drug Information of ZELBORAF

Product NDC: 50242-090
Proprietary Name: ZELBORAF
Non Proprietary Name: Vemurafenib
Active Ingredient(s): 240    mg/1 & nbsp;   Vemurafenib
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of ZELBORAF

Product NDC: 50242-090
Labeler Name: Genentech, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202429
Marketing Category: NDA
Start Marketing Date: 20110817

Package Information of ZELBORAF

Package NDC: 50242-090-01
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-01) > 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

NDC Information of ZELBORAF

NDC Code 50242-090-01
Proprietary Name ZELBORAF
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-01) > 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product NDC 50242-090
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Vemurafenib
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110817
Marketing Category Name NDA
Labeler Name Genentech, Inc.
Substance Name VEMURAFENIB
Strength Number 240
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of ZELBORAF


General Information